MedTrace Logo

Cognition and Patients With Lung Cancer

NCT07160751 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2025-11-20

No results posted yet for this study

Summary

Cognitive complaints in patients treated for cancer can impact their quality of life.

Studies show that these cognitive complaints may have multifactorial origins and appear at different stages of the care pathway.

In a population of patients treated for confirmed localized non-small cell lung cancer (NSCLC), this study aims to detect and monitor the onset of cognitive complaints over time.

The timing of the complaints during the treatment, the cognitive functions affected (memory, attention, concentration…), as well as the perceived intensity of the discomfort, will be examined.

The study also explores the influence of co-factors such as mood, fatigue, socio-cultural status, and level of social vulnerability on these cognitive complaints.

Conditions

  • Localized, Operable Non-small Cell Lung Cancer

Interventions

OTHER

Self-questionnaire

FACT-Cog, HADS, FA12, EPICES, socio-professional and socio-demographic questionnaire

OTHER

Cognitive tests

Hopkins Verbal Learning Test (HVLT). Trail Making Test (TMT). Verbal fluency test. Digit memory WAIS-IV.

OTHER

Assessment of the impact of social vulnerability on patient complaints

EPICES at month 12

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Isabelle HARDY LEGER · Hôpital Cochin, Assistance Publique-Hôpitaux de Paris - Service de pneumologie.

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2028-01-31
Completion
2029-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07160751 on ClinicalTrials.gov